Search - tctmd.com

Displaying 421 - 440 of 494

Presentation TCT 2012

Healing Responses After Bifurcation Stenting with the Dedicated TRYTON Side-Branch Stent in Combination with XIENCE V Stents: an Angiography and Optical Coherence Tomography Study.

Presenter: Christophe L. Dubois, Tom Adriaenssens, Giovanni Ughi, Mark Coosemans, Bert Ferdinande, Peter Sinnaeve, Walter Desmet

January 03, 2012

Presentation TCT 2012

An All Comers Randomized Trial Comparing Xience Prime and Promus Element Stents. Preliminary Results.

Presenter: Jose M. De la Torre Hernandez, Tamara Garcia Camarero, Piedad Lerena, Dae-Hyun Lee, Fermin Sainz Laso, Virginia Frances Santamaria, Monica Fernandez Menendez, Gonzalo Martin Gorria, Javier Zueco

January 03, 2012

News Industry News

Abbott Initiates Clinical Trial to Evaluate the Absorb™ Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent

December 07, 2011

News Daily News

Some New-Generation Stents Prone to Longitudinal Distortion

November 29, 2011

News Conference News

TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year

L.A. McKeown

November 28, 2011

News Industry News

Resolute stent showed positive 1-year results in patients with diabetes

November 09, 2011

News Conference News

RAPID GENE: Validation of Point-of-Care Genetic Testing

November 09, 2011

News Conference News

ZES and SES Equally Effective in Long Lesion Treatment

November 08, 2011

News Conference News

SPIRIT PRIME: EES Efficacy ‘Similar and Consistent’ with Xience V Technology

November 08, 2011

News Conference News

Safety, Efficacy Reported with FIREHAWK SES

November 08, 2011

News Conference News

Preclinical Results Promising for Combo Stent

November 08, 2011

News Conference News

Low Event Rates with EES Sustained at 2 Years

November 08, 2011

News Conference News

EES Compared Favorably with SES In Two Pivotal Trials

November 08, 2011

News Conference News

Bioabsorbable Polymers, Scaffolds Offer Permanent Advantages

November 08, 2011

News Conference News

ZES, EES Noninferior to PES

November 07, 2011

News Industry News

Medtronic Resolute(R) Drug-Eluting Stent Shows Strong Results, Even in Challenging Diabetes Patients with Coronary Disease

November 07, 2011

News Conference News

EES Associated with Reduced MACE Compared with SES

November 07, 2011

News Conference News

Early Discontinuation of DAPT May Increase Risk of Stent Thrombosis

November 06, 2011

News Conference News

DES Noninferior for Survival Compared with BMS in STEMI

November 06, 2011

News Industry News

Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011

November 04, 2011

Advertisement

Healing Responses After Bifurcation Stenting with the Dedicated TRYTON Side-Branch Stent in Combination with XIENCE V Stents: an Angiography and Optical Coherence Tomography Study.

An All Comers Randomized Trial Comparing Xience Prime and Promus Element Stents. Preliminary Results.

Abbott Initiates Clinical Trial to Evaluate the Absorb™ Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent

Some New-Generation Stents Prone to Longitudinal Distortion

TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year

Resolute stent showed positive 1-year results in patients with diabetes

RAPID GENE: Validation of Point-of-Care Genetic Testing

ZES and SES Equally Effective in Long Lesion Treatment

SPIRIT PRIME: EES Efficacy ‘Similar and Consistent’ with Xience V Technology

Safety, Efficacy Reported with FIREHAWK SES

Preclinical Results Promising for Combo Stent

Low Event Rates with EES Sustained at 2 Years

EES Compared Favorably with SES In Two Pivotal Trials

Bioabsorbable Polymers, Scaffolds Offer Permanent Advantages

ZES, EES Noninferior to PES

Medtronic Resolute(R) Drug-Eluting Stent Shows Strong Results, Even in Challenging Diabetes Patients with Coronary Disease

EES Associated with Reduced MACE Compared with SES

Early Discontinuation of DAPT May Increase Risk of Stent Thrombosis

DES Noninferior for Survival Compared with BMS in STEMI

Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content